Mental Health Clinics in Carmi, IL Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Egyptian Health Department Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1705 College Ave, Carmi, IL 62821 Phone: 618-382-7311 Fax: 618-382-7552 |
Illinois Baptist Children's Home And Family Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 949 County Road 1300 N, Carmi, IL 62821 Phone: 618-328-4164 Fax: 618-382-3239 |
Southeastern Illinois Center For Pastoral Counseling Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 S Church St, Carmi, IL 62821 Phone: 618-382-5548 |
Wisemind Counseling And Consulting, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 304 E Robinson St Ste 206b, Carmi, IL 62821 Phone: 407-227-8150 |
Egyptian Health Department Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1705 College Ave, Carmi, IL 62821 Phone: 618-273-3326 Fax: 618-273-2808 |
News Archive
LSU Health New Orleans finalizes deal with CB BioSciences
The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience.
SFU researchers develop optical diagnostic probe for non-invasive detection of breast cancer
Simon Fraser University researchers have created a patent-pending, optical diagnostic probe capable of safely and non-invasively detecting early stage breast cancer.
VARI, Gentel Biosciences receive U.S. Patent for new glycan detection technology
Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute, a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide. Gentel first obtained an exclusive right to commercialize the technology in 2006.
FDA issues CRL to Jazz for JZP-6 NDA for fibromyalgia
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.
› Verified 3 days ago